BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Galey JB, Bombard S, Chopard C, Girerd JJ, Lederer F, Thang DC, Nam NH, Mansuy D, Chottard JC. Hexanal phenylhydrazone is a mechanism-based inactivator of soybean lipoxygenase 1. Biochemistry. 1988;27:1058-1066. [PMID: 2835075 DOI: 10.1097/meg.0000000000000840] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 . UEG Week 2019 Oral Presentations. United European Gastroenterol J 2019;7:10-188. [PMID: 32213000 DOI: 10.1177/2050640619854670] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Iglay K, Bennett D, Kappelman MD, Thai S, Aldridge M, Karki C, Cook SF. A systematic review of the patient burden of Crohn’s disease-related rectovaginal and anovaginal fistulas. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-021-02079-8] [Reference Citation Analysis]
3 García-Olmo D, Van Assche G, Tagarro I, Diez MC, Richard MP, Khalid JM, van Dijk M, Bennett D, Hokkanen SRK, Panés J. Prevalence of Anal Fistulas in Europe: Systematic Literature Reviews and Population-Based Database Analysis. Adv Ther 2019;36:3503-18. [PMID: 31656013 DOI: 10.1007/s12325-019-01117-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
4 Hirsch RD, Keung C, Con D, Vasudevan A, Van Langenberg DR, Niewiadomski O. Direct health care costs of managing perianal Crohn's Disease in a population based cohort. Scand J Gastroenterol 2021;:1-7. [PMID: 34932436 DOI: 10.1080/00365521.2021.2016944] [Reference Citation Analysis]
5 Kochar B, Barnes EL, Herfarth HH, Martin CF, Ananthakrishnan AN, McGovern D, Long M, Sandler RS. Asians have more perianal Crohn disease and ocular manifestations compared with white Americans. Inflamm Intest Dis 2018;2:147-53. [PMID: 29876356 DOI: 10.1159/000484347] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sørensen KM, Jensen CH, Sheikh SP, Qvist N, Sørensen JA. Treatment of Fistulizing Perianal Crohn's Disease by Autologous Microfat Enriched With Adipose-Derived Regenerative Cells. Inflamm Bowel Dis 2021:izab276. [PMID: 34791256 DOI: 10.1093/ibd/izab276] [Reference Citation Analysis]
7 Song EM, Lee HS, Kim YJ, Oh EH, Ham NS, Kim J, Hwang SW, Park SH, Yang DH, Ye BD, Byeon JS, Myung SJ, Lee JL, Yoon YS, Yu CS, Yang SK. Incidence and Outcomes of Perianal Disease in an Asian Population with Crohn's Disease: A Nationwide Population-Based Study. Dig Dis Sci 2020;65:1189-96. [PMID: 31485994 DOI: 10.1007/s10620-019-05819-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wiseman J, Chawla T, Morin F, de Buck van Overstraeten A, Weizman AV. A Multi-Disciplinary Approach to Perianal Fistulizing Crohn's Disease. Clin Colon Rectal Surg 2022;35:051-7. [DOI: 10.1055/s-0041-1740038] [Reference Citation Analysis]
9 Park SH, Aniwan S, Scott Harmsen W, Tremaine WJ, Lightner AL, Faubion WA, Loftus EV. Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based Cohort. Inflamm Bowel Dis. 2019;25:1054-1060. [PMID: 30346531 DOI: 10.1093/ibd/izy329] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
10 Hokkanen SR, Boxall N, Khalid JM, Bennett D, Patel H. Prevalence of anal fistula in the United Kingdom. World J Clin Cases 2019; 7(14): 1795-1804 [PMID: 31417925 DOI: 10.12998/wjcc.v7.i14.1795] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
11 Tsai L, McCurdy JD, Ma C, Jairath V, Singh S. Epidemiology and Natural History of Perianal Crohn's Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts. Inflamm Bowel Dis 2021:izab287. [PMID: 34792604 DOI: 10.1093/ibd/izab287] [Reference Citation Analysis]